Histopathology is still the golden standard for the diagnosis of clinical diseases. Whole slide image (WSI) can make up for the shortcomings of traditional glass slices, such as easy damage, difficult retrieval and poor diagnostic repeatability, but it also brings huge workload. Artificial intelligence (AI) assisted pathologist's WSI analysis can solve the problem of low efficiency and improve the consistency of diagnosis. Among them, the convolution neural network (CNN) algorithm is the most widely used. This article aims to review the reported application of CNN in WSI image analysis, summarizes the development trend of CNN in the field of pathology and makes a prospect.
Lung cancer is a malignant tumor with the highest mortality worldwide, and its early diagnosis and evaluation have a crucial impact on the comprehensive treatment of patients. Early preoperative diagnosis of lung cancer depends on a variety of imaging and tumor marker indicators, but it cannot be accurately assessed due to its high false positive rate. Liquid biopsy biomarkers can detect circulating tumor cells and DNA in peripheral blood by non-invasive methods and are gradually becoming a powerful diagnostic tool in the field of precision medicine for tumors. This article reviews the research progress of liquid biopsy biomarkers and their combination with clinical imaging features in the early diagnosis of lung cancer.
ObjectiveTo establish a machine learning model based on computed tomography (CT) radiomics for preoperatively predicting invasive degree of lung ground-glass nodules (GGNs). MethodsWe retrospectively analyzed the clinical data of GGNs patients whose solid component less than 3 cm in the Department of Thoracic Surgery of Shanghai Pulmonary Hospital from March 2021 to July 2021 and the First Hospital of Lanzhou University from January 2019 to May 2022. The lesions were divided into pre-invasiveness and invasiveness according to postoperative pathological results, and the patients were randomly divided into a training set and a test set in a ratio of 7∶3. Radiomic features (1 317) were extracted from CT images of each patient, the max-relevance and min-redundancy (mRMR) was used to screen the top 100 features with the most relevant categories, least absolute shrinkage and selection operator (LASSO) was used to select radiomic features, and the support vector machine (SVM) classifier was used to establish the prediction model. We calculated the area under the curve (AUC), sensitivity, specificity, accuracy, negative predictive value, positive predictive value to evaluate the performance of the model, drawing calibration and decision curves of the prediction model to evaluate the accuracy and clinical benefit of the model, analyzed the performance in the training set and subgroups with different nodule diameters, and compared the prediction performance of this model with Mayo and Brock models. Two primary thoracic surgeons were required to evaluate the invasiveness of GGNs to investigate the clinical utility of the model. ResultsA total of 400 patients were divided into the training set (n=280) and the test set (n=120) according to the admission criteria. There were 267 females and 133 males with an average age of 52.4±12.7 years. Finally, 8 radiomic features were screened out from the training set data to build SVM model. The AUC, sensitivity and specificity of the model in the training and test sets were 0.91, 0.89, 0.75 and 0.86, 0.92, 0.60, respectively. The model showed good prediction performance in the training set 0-10 mm, 10-20 mm and the test set 0-10 mm, 10-20 mm subgroups, with AUC values of 0.82, 0.88, 0.84, 0.72, respectively. The AUC of SVM model was significantly better than that of Mayo model (0.73) and Brock model (0.73). With the help of this model, the AUC value, sensitivity, specificity and accuracy of thoracic surgeons A and B in distinguishing invasive or non-invasive adenocarcinoma were significantly improved. ConclusionThe SVM model based on radiomics is helpful to distinguish non-invasive lesions from invasive lesions, and has stable predictive performance for GGNs of different sizes and has better prediction performance than Mayo and Brock models. It can help clinicians to more accurately judge the invasiveness of GGNs, to make more appropriate diagnosis and treatment decisions, and achieve accurate treatment.